News und Analysen

In today's video, I discuss recent updates impacting Advanced Micro Devices (NASDAQ: AMD) and Nvidia (NASDAQ: NVDA). To learn more, check out the short video, consider subscribing, and click the

Growth stocks have been rallying in recent weeks, and that's usually great news for Cathie Wood. The founder, CEO, and stock-picking ace of the Ark Invest family of exchange-traded funds (ETFs) has

Some research has shown that dividend-paying stocks significantly outperformed their non-dividend-paying peers over the past few decades, and that the lion's share of market returns can be

Even when equities are volatile, investors can find great stocks to buy. And the rules for investing in the current environment aren't that different, at least for those focused on the long game

The average stock on the S&P 500 yields just 1.4%. If you invested $54,000 into stocks averaging that kind of a yield, you'd collect just $756 in annual dividend income. But if you invested that

Shares of commercial-stage biotech Geron (NASDAQ: GERN) couldn't quite surmount the hump of Hump Day. After the company released its latest set of quarterly figures, its stock price wobbled as

In this video, I will cover Advanced Micro Devices' (NASDAQ: AMD) recent earnings report and explain why the stock barely moved after a strong earnings beat. Watch the short video to learn more

Shares of Rigetti Computing (NASDAQ: RGTI) surged higher in April. The company's stock gained 12% over the course of the month. The strong performance came as the S&P 500 and the Nasdaq Composite

Venerable telecom titan AT&T (NYSE: T) is on a roll. Its shares soared to a 52-week high of $29.03 in April, the highest it's been since before the COVID-19 pandemic.This result is a dramatic

In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD). To learn more, check out the short video, consider subscribing, and click the special offer link below.

Summit Therapeutics (NASDAQ: SMMT) has more than just a potential blockbuster cancer drug in its portfolio. Ivonescimab could be one of the best drugs to ever hit the market. This has investors

Shares of Advanced Micro Devices (NASDAQ: AMD) rose 1.8% in Tuesday's after-hours trading, following the chipmaker's release of its first-quarter 2025 report.

The stock's gain is attributable to

Vertex Pharmaceuticals' (NASDAQ: VRTX) remarkable momentum came to a screeching halt this week. The big biotech stock had been up well over 20% year to date. However, Vertex's shares plunged after

Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) were sinking 11.9% as of 10:18 a.m. ET on Tuesday. The sharp decline came after the company announced its 2025 first-quarter results on Monday

Here's our initial take on Vertex Pharmaceuticals' (NASDAQ: VRTX) first-quarter financial report.

Vertex's first-quarter financial results didn't keep up with what investors have gotten used to

One of the best catalysts for a stock's rise is the withdrawal of a rival. That was an important dynamic behind the double-digit-percentage rise of biotech Viking Therapeutics' (NASDAQ: VKTX) stock

The concerns around tariffs and the impact on the economy triggered a sharp sell-off for stocks recently. But this uncertainty hasn't seemed to slow the momentum for the artificial intelligence (AI)

In today's video, I discuss Advanced Micro Devices (NASDAQ: AMD) and what investors should know before the company reports earnings. To learn more, check out the short video, consider subscribing,

Any time is a great time to buy stocks -- if you pick the right stocks. That's true even in May, a month where some investors have traditionally opted to take a break from the stock market for the

The launch of ChatGPT on Nov. 30, 2022 represented one of the leading catalysts that sparked the revolution around artificial intelligence (AI). Since that date, shares of semiconductor stock Nvidia

Investors often view Pharmaceutical stocks as safe havens during periods of market turbulence. Stock market volatility or even economic downturns usually don't affect drugmakers' underlying

Investing in excellent dividend stocks can be a great strategy to mitigate risk and boost long-term returns. Companies that can dispense regular payouts to their shareholders -- especially those